Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Buy Low With Insiders: Three Struggling Companies Registering Heavy Insider Buying

Page 1 of 2

The major U.S. stock indexes registered the largest one-day losses on Thursday in the past month or so, thanks to the falling energy equities yet again as the broader stock market sentiment reversed quite surprisingly after the Labor Department released the stronger-than-expected jobs report last Friday, which increased the odds of the Federal Reserve raising rates this year. Meanwhile, some companies’ insiders have been ignoring the crowd and started piling up more shares of their companies, which suggests their conviction in the strong future performance of their companies. When insiders buy shares amid high uncertainty and turmoil, their moves are worth even more attention. The Insider Monkey team pinpointed three companies that have registered heavy insider buying activity so far this week, so let’s attempt to find out what might have guided insiders to buy stock.

Fun Activities for Work Parties

Most investors can’t outperform the stock market by individually picking stocks because stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned 102% over the ensuing 37 months, outperforming the S&P 500 Index by more than 53 percentage points (read more details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

Shoe manufacturer Crocs Inc. (NASDAQ:CROX) has seen two insiders purchase shares so far this trading week. Chief Executive Officer Gregg Ribatt acquired a 15,000-share block on Tuesday at a weighted average price of $9.98, boosting his overall holdings to 716,087 shares. Director Thomas J. Smach also snapped up 15,000 shares on the same day at prices ranging from $9.91-to-$10.10 per share. Following the recent purchase, the Director currently holds a stake of 124,215 shares. The shares of the footwear company are down 25% this year, after the company slashed its third-quarter guidance at the end of September and posted a weaker-than-expected earnings report earlier this month. Several financial services hubs recently cut the price targets on Crocs Inc. (NASDAQ:CROX) and/or downgraded the stock. Earlier this month, equity research firm Monness Crespi Hardt slashed its price target on the Crocs’ stock to $13 from $17, reiterating its ‘Buy’ rating. The shoe manufacturer received some attention from the hedge funds monitored by Insider Monkey during the second quarter, as the number of money managers invested in the company increased to 23 from 17 quarter-on-quarter. Orlando Muyshondt’s Tyrian Investments held an 1.66-share position in Crocs Inc. (NASDAQ:CROX) at the end of the second quarter.

Follow Crocs Inc. (NASDAQ:CROX)
Trade (NASDAQ:CROX) Now!

The second page of this daily insider trading article discloses the insider buying activity at HCP Inc. (NYSE:HCP) and Blucora Inc. (NASDAQ:BCOR).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!